Genetic heart disease Flashcards
types of genetic cardiac disease
cardiovascular connective tissue disease, familial arrhythmias, familial cardiomyopathy
cardiovascular connective tissue diseases
marfan, loeys Dietz, vascular ehlers-danolos, syndromic, non-syndromic familial thoracic aortic aneurysms
marfan syndrome
autosomal dominant, multisystem, connective tissue, mutation on the fibrillar 1 gene on chromosome 15, clinically overlaps with joeys dietz syndrome, other aortopathies and some forms of EDS. difficult to diagnose, needs too positive findings, features show over time
Ghent nosology
diagnosis of Marfan rests on two positive findings on 5 sections- CVS eg aortic dilatation/dissection, eyes, systemic score more than 7, unequivocally affected relative, mutation that causes MFS
iridodenesis
feature of marfans, shaking iris
marfans clinical assessment
Ghent 2010 features, arrange echo to measure diameter of sinus of Valsalva, x ray for protrusio, MRI for dural extasia, undertake genetic testing
losartan
TGF beta antagonist ( TGF beta affects cell proliferation, differentiation and apoptosis. those deficient in fibrillar have excess TGFbeta and marfan features)
medical management of marfan
aortic stiffness and risk of rupture increases with aortic diameter so management aims to reduce diameter, control BP, surgical intervention if risk of rupture is too high. at least annual clinical review- echo, B blockers, angiotensin II receptor blockers, prphylactic aortic surgery if sinus of Valsalva exceeds 5.5cm or 5% great per year, monitor aortic root frequently in pregnancy if diameter exceeds 4cm
surgical intervention for marfans syndrome
aortic root surgery- mechanical valve (lasts longer but needs anticoagulant), valve sparing procedure (may need reoperation but no anticoagulant), use of Dacron to go around aorta
long QT syndrome- romano-ward syndrome.
autosomal dominant. syncope, seizure, sudden death, triggered by emotion, exercise drugs.ECG shows prolonged QTc interval, depolarisation anomalies, paroxysmal polymorphic VT
long QT syndrome- Jerrell lange-neilsen
autosomal recessive. syncope, seizure, sudden death, triggered by emotion, exercise drugs.ECG shows prolonged QTc interval, depolarisation anomalies, paroxysmal polymorphic VT and congenital sensorineural deafness
long QT 1 are caused by
changes in the potassium channel genes
long QT 2 are caused by
changes in the potassium channels genes
long QT 3 are caused by
changes in sodium channel genes
why do long QT intervals cause ventricular tachycardia
another wave of depolarisation comes before the cells are fully recovered from the previous one
genotype mutation prediction if exercise particularlt swimming exacerbates it
normal/ broad T wave, KCNQ1
genotype mutation prediction if noise or arousal exacerbates it
notched t wave, KCNH2
genotype mutation prediction if sleep or bradycardia exacerbates it
biphasic t wave, SCN5A
brugada syndrome
arrhythmia disorder, syncope, seizure , sudden death, usually a SCN5A disorder, occurs more in young men in Far East arrhythmia occurs during sleep, avoid excess alcohol, fever, overeating for management, can get an implanted cardiac defibrillator
ARVC
arrhythmia disorder, Rv dyskinesia which is shown on MRI or echo, epsilon waves and T wave inversion which I shown on ECG, late potentials, effort induced VT, fatty infiltration of right ventricle, family history or pathogenic gene variant
hypertrophic cardiomyopathy sarcomere disease
heart muscle is thickened and enlarged, common but mild and doesn’t develop symptoms until later in life, usually caused by mutation in MYBPC3 and MYH7, causes arrythmia, ventricular tachycardia
titan truncating variants
Titin is the largest human protein and a crucial component of all striated muscle, in which it has structural, sensory, and signaling functions. TTNs account for 10% of all dilated cardiomyopathy, 25% of familial dilated cardiomyopathy, 10% of apparently alcoholic DCM, 10% of pregnancy associated DCM, variable penetrance and can act as a susceptibility factor in some cases
dilated cardiomyopathy management
first rule out conditions before doing genetic testing so do test to find if ischaemic heart disease, hypertension, skeletal muscle disease, alcohol abuse, exposure to cardio toxic drugs, haemochromatosis, mitochondrial disorder, family history of cardiomyopathy, genetic testing last for TTN, LMNA, MYH7, MYBPC3 etc
massively parallel sequencing
enables to test massive parts of the genome, long runs of DNA, do gene panels, whole exome and whole genome, the more genes you sequence the more variants you find
categories for pathogenicity of variants
pathogenic, likely pathogenic, uncertain, likely benign, benign
what to look at when classifying pathogenicity of variants
is it nonsense, missesnse, splicing, deletion, promotor, regulatory
VEP software
literature reports
phenotype match
variant frequency in apparent normal population
segregation in family
de novo or not